SPL
Click for more information
0.00% 8.9¢ starpharma holdings limited

If Viraleze 7 day treatment is competing with Paxlovid - who wins, page-2

  1. Maz2024
    44 Posts.
    lightbulb Created with Sketch. 4
    clock Created with Sketch.
    29/03/24
    09:35
    Post #: 73115677
    Interesting
    Cochrane international reference reports only 2 Human studies that are relevant. Awaiting the peer reviewed paper on UK NHS Ashford and St Peter’s placebo study
    SPL Price at posting: 12.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
8.9¢ 		Change
0.000(0.00%) 		Mkt cap ! $36.67M
Open High Low Value Volume
9.0¢ 9.1¢ 8.7¢ $257.5K 2.884M

Buyers (Bids)

No. Vol. Price($)
3 119243 8.6¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 60378 1
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.